// App-Quantinova.ai

e21077 : Prognostic significance of circulating tumor cell (CTC) levels at various times during first- and second-line chemotherapy for metastatic breast cancer (MBC).

Researchers

Presenter

  • Rafael Arteta-Bulos

Principal Investigators

  • Paul J. E. Miller

  • Rebecca S. Overbury

  • Alison Schwartzberg

  • Mark S. Walker

  • Lee Steven Schwartzberg

Medical Centers

  • ACORN Research and The West Clinic, Memphis, TN

  • The University of Tennessee Health Science Center, Memphis, TN

  • ACORN Research LLC, Memphis, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved